COVID-19 Vaccination in Rheumatic Disease Patients
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Systemic Lupus Erythematosus
Related studies linked through entity extraction aliases.
Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients
- Status
- RECRUITING
- Phase
- PHASE2
ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE2
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
- Status
- RECRUITING
- Phase
- N/A
An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- PHASE2
Expression of CXCR4 in Patients With Systemic Lupus Erythematosus
- Status
- UNKNOWN
- Phase
- N/A
Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory Diseases
- Status
- COMPLETED
- Phase
- N/A
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- N/A
Anifrolumab Early Access Program
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Study of Leukocyte Populations in Patients With Chronic Inflammatory
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Objective Measurement With TCM Pattern for AIDDES
- Status
- UNKNOWN
- Phase
- N/A
A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus
- Status
- TERMINATED
- Phase
- PHASE1
Belimumab in Patients With Systemic Lupus Erythematosus
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Epigenetics in Lupus Nephritis
- Status
- UNKNOWN
- Phase
- N/A
Study of M5049 in CLE and SLE Participants
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- N/A
Transcriptional and Immune Parameters of Response to Belimumab
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage
- Status
- UNKNOWN
- Phase
- NA
Monogenic Lupus in Childhood Onset Systemic Lupus Erythematosus
- Status
- RECRUITING
- Phase
- N/A